Enlivex Therapeutics
ENLV
ENLV
19 hedge funds and large institutions have $1.24M invested in Enlivex Therapeutics in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
19
Holding in Top 10
–
Calls
$449K
Puts
$24K
Top Buyers
| 1 | +$52K | |
| 2 | +$16.5K | |
| 3 | +$1.82K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$695 |
Top Sellers
| 1 | -$36.6K | |
| 2 | -$7.25K | |
| 3 | -$3.82K | |
| 4 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
-$3.72K |
| 5 |
Morgan Stanley
New York
|
-$2.06K |